154 related articles for article (PubMed ID: 37285183)
1. Analysis of Dispensing and Utilization Patterns of Medical Cannabis Products in State Licensed Cannabis Dispensaries.
Tanco K; Olson A; Fellman B; Jankowski M; Lai SY; Shete S; Harbison K; Scheid J; Bruera E
J Palliat Med; 2023 Nov; 26(11):1482-1487. PubMed ID: 37285183
[No Abstract] [Full Text] [Related]
2. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.
Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N
PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169
[TBL] [Abstract][Full Text] [Related]
3. Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York State.
Kim A; Kaufmann CN; Ko R; Li Z; Han BH
J Palliat Med; 2019 Oct; 22(10):1196-1201. PubMed ID: 30909786
[No Abstract] [Full Text] [Related]
4. Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients.
Dobbins M; Rakkar M; Cunnane K; Pennypacker SD; Wagoner KG; Reboussin BA; Romero-Sandoval EA
Front Public Health; 2022; 10():893009. PubMed ID: 35784239
[TBL] [Abstract][Full Text] [Related]
5. Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends.
Lyu X; Illamola SM; Marino SE; Leppik IE; Dahmer S; Lehfeldt P; Conway JM; Remmel RP; Kingsley K; Birnbaum AK
Curr Ther Res Clin Exp; 2023; 99():100709. PubMed ID: 37538850
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Medical Cannabis Use Among Older Adults from a Cannabis Dispensary in New York State.
Kaufmann CN; Kim A; Miyoshi M; Han BH
Cannabis Cannabinoid Res; 2022 Apr; 7(2):224-230. PubMed ID: 33998868
[No Abstract] [Full Text] [Related]
7. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
Hammond D; Goodman S
Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
[No Abstract] [Full Text] [Related]
8. Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis.
Freeman TP; Craft S; Wilson J; Stylianou S; ElSohly M; Di Forti M; Lynskey MT
Addiction; 2021 May; 116(5):1000-1010. PubMed ID: 33160291
[TBL] [Abstract][Full Text] [Related]
9. What Do You Know About Maryjane? A Systematic Review of the Current Data on the THC:CBD Ratio.
Zeyl V; Sawyer K; Wightman RS
Subst Use Misuse; 2020; 55(8):1223-1227. PubMed ID: 32124675
[No Abstract] [Full Text] [Related]
10. Medical Cannabis Use and Inflammatory Cytokines and Chemokines Among Adult Chronic Pain Patients.
Ajrawat P; Yang Y; Wasilewski E; Leroux T; Ladha KS; Bhatia A; Singh M; Thaker S; Kapoor M; Furlan AD; Kotra LP; Clarke H
Cannabis Cannabinoid Res; 2024 Feb; 9(1):267-281. PubMed ID: 36342776
[No Abstract] [Full Text] [Related]
11. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina.
Fernández N; Cappello MG; Quiroga PN
Forensic Sci Int; 2023 Aug; 349():111762. PubMed ID: 37392612
[TBL] [Abstract][Full Text] [Related]
12. Authorization Patterns, Safety, and Effectiveness of Medical Cannabis in Quebec.
Kalaba M; MacNair L; Peters EN; Eglit GML; Rapin L; Hage CE; Prosk E; Ware MA
Cannabis Cannabinoid Res; 2021 Dec; 6(6):564-572. PubMed ID: 33998902
[No Abstract] [Full Text] [Related]
13. Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying THC, CBD and their metabolites in hair. Application to patients treated with medical cannabis.
Lo Faro AF; Venanzi B; Pilli G; Ripani U; Basile G; Pichini S; Busardò FP
J Pharm Biomed Anal; 2022 Aug; 217():114841. PubMed ID: 35636009
[TBL] [Abstract][Full Text] [Related]
14. Chemical profiling of Cannabis varieties cultivated for medical purposes in southeastern Brazil.
Carvalho VM; de Almeida FG; de Macêdo Vieira AC; Rocha ED; Cabral LM; Strongin RM
Forensic Sci Int; 2022 Jun; 335():111309. PubMed ID: 35462181
[TBL] [Abstract][Full Text] [Related]
15. Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use.
Pichini S; Mannocchi G; Berretta P; Zaami S; Pirani F; Pacifici R; Busardò FP
Ther Drug Monit; 2020 Feb; 42(1):151-156. PubMed ID: 31389860
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes.
Morean ME; Lederman IR
Addict Behav; 2019 Jun; 93():233-239. PubMed ID: 30772776
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.
Fedorova EV; Wong CF; Ataiants J; Iverson E; Conn BM; Lankenau SE
Drug Alcohol Depend; 2021 Apr; 221():108648. PubMed ID: 33676073
[TBL] [Abstract][Full Text] [Related]
18. Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey.
Boehnke KF; Gagnier JJ; Matallana L; Williams DA
J Pain; 2021 Nov; 22(11):1418-1428. PubMed ID: 33992787
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products.
Bergeria CL; Spindle TR; Cone EJ; Sholler D; Goffi E; Mitchell JM; Winecker RE; Bigelow GE; Flegel R; Vandrey R
J Anal Toxicol; 2022 Jul; 46(6):583-591. PubMed ID: 35438179
[TBL] [Abstract][Full Text] [Related]
20. Impact of marijuana legalization on cannabis-related visits to the emergency department.
Tolan NV; Terebo T; Chai PR; Erickson TB; Hayes BD; Uljon SN; Petrides AK; Demetriou CA; Melanson SEF
Clin Toxicol (Phila); 2022 May; 60(5):585-595. PubMed ID: 34935567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
